LANGaware Awarded Patient Engagement Solutions Agreement With Premier, Inc. for Early Detection of Cognitive and Behavioral Health Diseases
LANGaware Awarded Patient Engagement Solutions Agreement With Premier, Inc. for Early Detection of Cognitive and Behavioral Health Diseases
NEW YORK, July 17, 2024 /PRNewswire/ -- LANGaware, a pioneering AI-driven healthcare technology company, has been awarded a national group purchasing agreement for Patient Engagement Solutions with Premier, Inc. Effective July 1st, 2024, the new agreement allows Premier members, at their discretion, access to LANGaware's advanced screening technology at special pricing and terms pre-negotiated by Premier.
LANGaware是一傢俱有開創性的人工智能驅動的醫療保健技術公司,在2024年7月1日獲得了國家組購協議,提供患者參與解決方案。新的協議允許Premier的會員根據自己的意願以特價和條款獲得LANGaware先進的篩選技術。
LANGaware utilizes AI to predict and monitor neurodegenerative and behavioral health conditions such as Mild Cognitive Impairment (MCI), Alzheimer's Disease (AD), and Depression. By analyzing digital biomarkers based on language, voice, and speech, LANGaware's platform offers unmatched accuracy in early detection, leading to improved patient outcomes, enhanced quality of life, and reduced healthcare costs. The integration of LANGaware's technology can help providers reduce costs through enhanced early diagnosis and timely interventions, while also driving revenue by offering a new billable service and improving patient satisfaction with accurate and efficient assessments.
LANGaware利用人工智能技術預測和監測神經退行性和行爲健康狀況,如輕度認知損害(MCI),阿爾茨海默病(AD)和抑鬱症。通過分析基於語言、語音和言語的數字生物標誌物,LANGaware的平台提供了無與倫比的早期檢測精度,從而改善了患者的預後,提高了生活質量,降低了醫療保健成本。LANGaware技術的整合可以幫助供應商通過提供新的可計費服務和改進精確和高效的評估來減少成本,並通過增強早期診斷和及時干預來推動收入。
Developed through years of rigorous research and testing, LANGaware's patented technology is transforming early cognitive and behavioral health disease detection. By minimizing the risk of misdiagnosis and unnecessary treatments, LANGaware provides healthcare providers with a powerful tool for early detection, personalized support, and treatment monitoring.
LANGaware通過多年的嚴格研究和測試開發了自己的專利技術,改變了早期認知和行爲健康疾病的檢測。通過最小化誤診和不必要治療的風險,LANGaware爲醫療保健提供者提供了一種早期檢測、個性化支持和治療監測的強大工具。
"We are thrilled to join Premier's network and extend our digital assessment tool's reach to more patients, hospitals, and providers," said Vassiliki Rentoumi, Founder and CEO of LANGaware. "Our goal is to revolutionize early diagnosis, improve patient outcomes, and drive positive changes in the healthcare industry."
LANGaware的創始人兼首席執行官Vassiliki Rentoumi表示:“我們很高興加入Premier網絡,並擴大我們的數字評估工具對更多患者、醫院和服務提供商的覆蓋範圍。我們的目標是改革早期診斷,改善患者預後,並推動醫療保健行業的積極變革。”
This collaboration marks a significant step forward in expanding access to advanced diagnostic services across the United States. Combining Premier's extensive member network with LANGaware's cutting-edge technology aims to revolutionize healthcare through innovative solutions.
此次合作標誌着在美國擴大先進診斷服務的重要一步。將Premier的廣泛會員網絡與LANGaware的尖端技術相結合,旨在通過創新解決方案改革醫療保健領域。
Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,350 U.S. hospitals and 300,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, consulting and other services, Premier enables better care and outcomes at a lower cost.
Premier是一個領先的醫療保健改進公司,聯合了約4,350個美國醫院和300,000名其他提供者,以改革醫療保健。通過集成數據和分析、協作、供應鏈解決方案、諮詢等服務,Premier能夠在降低成本的同時提供更好的護理和預後。
LANGaware leverages AI technology to revolutionize cognitive and behavioral health screening. By utilizing speech analysis and proprietary voice and speech biomarkers, LANGaware provides early, accurate and objective detection of conditions, enabling more effective treatments, reducing healthcare burdens, and improving overall well-being. For more information about LANGaware, please visit .
LANGaware利用人工智能技術來改變認知和行爲健康篩查。通過利用語音分析和專有的聲音和語音生物標誌物,LANGaware提供了早期、準確和客觀的疾病檢測,從而實現更有效的治療,減輕醫療負擔,提高整體幸福感。有關LANGaware的更多信息,請訪問。
Media Contacts:
Virginia Korma
646-878-9063
[email protected]
媒體聯繫人:
Virginia Korma
646-878-9063
[email protected]
SOURCE LANGaware
LANGaware資源